CD8A and myeloid sarcoma: Interestingly, intrinsic immune regulation of neuroantigen-specific CD8+ Treg was observed ex vivo in HC and treatment-naive RRMS patients (quiescent MS), whereas their suppressive activity was restricted in treatment-naïve MS patients during an episode of acute exacerbation [37].